Mirum Pharmaceuticals Inc (MIRM)

Mirum Pharmaceuticals Inc (MIRM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.3B; returns 1 day -3.3%, 1 week +0.3%, 1 year +15.8%.

Mirum Pharmaceuticals, Inc. (MIRM) is a biopharmaceutical company focused on developing and commercializing novel therapies for rare liver diseases. The company's revenue streams primarily come from net product sales.

Groups MIRM belongs to

• Biotechnology
• Rare Diseases
• Liver Disease
• Healthcare
• Biopharmaceutical
• Pharmaceuticals
• Gastroenterology
• Commercial Stage
• Commercial Stage Biotech
• Life Sciences
• Digestive Health

MIRM financial model: income statement, cash flow and balance sheet